Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Annual fiscal-year return on equity; no daily interpolation. Historical series through 2025-12-31.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
10.32%
RETURN ON EQUITY (ROE) AVG 3Y
-262.53%
RETURN ON EQUITY (ROE) AVG 5Y
-267.00%
RETURN ON EQUITY (ROE) AVG 10Y
-178.97%
RETURN ON EQUITY (ROE) AVG 15Y
-115.41%
RETURN ON EQUITY (ROE) AVG 20Y
-50.30%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MDxHealth S.A.
Market Cap
$30.67M
Return on Equity (ROE)
N/A
TTM Avg
10.32%
3Y Avg
-262.53%
5Y Avg
-267.00%
Market Cap
$30.94M
Return on Equity (ROE)
-15.29%
TTM Avg
-28.05%
3Y Avg
-476.74%
5Y Avg
-371.52%
Market Cap
$30.60M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$30.23M
Return on Equity (ROE)
-116.14%
TTM Avg
-228.74%
3Y Avg
113.10%
5Y Avg
76.03%
Market Cap
$30.33M
Return on Equity (ROE)
N/A
TTM Avg
29.33%
3Y Avg
173.42%
5Y Avg
64.03%
Market Cap
$31.44M
Return on Equity (ROE)
2.91%
TTM Avg
-2.27%
3Y Avg
5.52%
5Y Avg
6.87%
Market Cap
$29.83M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$32.08M
Return on Equity (ROE)
-86.96%
TTM Avg
-27.78%
3Y Avg
5.60%
5Y Avg
57.54%
Market Cap
$29.71M
Return on Equity (ROE)
-117.69%
TTM Avg
-1443.79%
3Y Avg
-971.02%
5Y Avg
-813.57%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $30.67M | N/A | 10.32% | -262.53% | -267.00% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.94M | -15.29% | -28.05% | -476.74% | -371.52% |
| CervoMed Inc. (CRVO)vs › | $30.60M | -132.18% | -94.77% | -38.62% | -46.78% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.23M | -116.14% | -228.74% | 113.10% | 76.03% |
| BeyondSpring Inc. (BYSI)vs › | $30.33M | N/A | 29.33% | 173.42% | 64.03% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.91% | -2.27% | 5.52% | 6.87% |
| Context Therapeutics Inc. (CNTX)vs › | $29.83M | -120.40% | -43.89% | -83.08% | -65.54% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.08M | -86.96% | -27.78% | 5.60% | 57.54% |
| Quantum Cyber N.V. (QUCY)vs › | $29.71M | -117.69% | -1443.79% | -971.02% | -813.57% |
| Rockwell Medical, Inc. (RMTI)vs › | $31.66M | -14.49% | -7.92% | -46.98% | -261.20% |
ROE
N/A
ROA
-22.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 277.15% |
| 2024-12-31 | -256.51% |
| 2023-12-31 | -597.95% |
| 2022-12-31 | -472.83% |
| 2021-12-31 | -61.84% |
| 2020-12-31 | -490.03% |
| 2019-12-31 | -218.52% |
| 2018-12-31 | -62.26% |
| 2017-12-31 | -28.22% |
| 2016-12-31 | -24.98% |
| 2015-12-31 | -32.70% |
| 2014-12-31 | -64.17% |
| 2013-12-31 | -65.92% |
| 2012-12-31 | -74.08% |
| 2011-12-31 | -61.37% |
| 2010-12-31 | -76.97% |
| 2009-12-31 | -76.07% |
| 2008-12-31 | -31.22% |
| 2007-12-31 | -29.23% |
| 2006-12-31 | -23.04% |
| 2005-12-31 | -42.44% |
| 2004-12-31 | -99.96% |
